JPMorgan Places Prudential on Positive Watch, Sees Hong Kong Fears as Overstated

JPMorgan has initiated a Positive Catalyst Watch on Prudential PLC (LON:PRU), asserting that the market is overly pessimistic about the impact of new Chinese regulations on the insurer's sales to mainland visitors in Hong Kong. The brokerage maintained its Overweight rating and 1,480 pence price target ahead of Prudential's first-half results, which are scheduled for August 26.

Hong Kong Regulatory Impact

Investor concerns have focused on China's Decree 837, a new regulatory framework for overseas investments by Chinese residents that took effect on July 1. JPMorgan's analysts believe the market is pricing in a worst-case scenario for Prudential's mainland Chinese visitor business.

The bank's note stated that while the new rules will likely increase compliance checks and lengthen sales processes, they do not anticipate an outright prohibition on compliant cross-border sales of Hong Kong insurance products. "We expect greater friction, but not an outright ban," the analysts wrote, suggesting that management will provide reassuring commentary in its upcoming earnings report.

Earnings and Valuation

JPMorgan forecasts continued operational momentum for Prudential in its first-half results. The brokerage projects:

Ad

• 15% growth in adjusted operating profit
• 13% growth in new business profit
• A modest expansion in new business margins, driven by health and protection product sales.

Despite slightly trimming its own earnings forecasts to account for lower investment returns, JPMorgan noted that its 2026 and 2027 estimates remain above the Bloomberg consensus. The analysts also argued that Prudential's stock is attractively valued, trading at a discount to European peers and regional rival AIA, despite offering stronger medium-term growth prospects.

Broader Growth Strategy

The report highlighted that investors may be overlooking Prudential's strategic diversification beyond Hong Kong. JPMorgan pointed to the insurer's expanding presence across Southeast Asia and its long-term ambitions to strengthen its position in the life and health insurance markets of India as key factors that could support growth if the Hong Kong market slows.